Radotinib Recruiting Phase 3 Trials for Leukemia, Myeloid, Chronic-Phase / Leukemia, Myeloid, Chronic Phase Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03459534A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs